Browse > Article
http://dx.doi.org/10.3839/jabc.2020.014

The anticancer effect of Bioconverted Danggui Liuhuang Decoction EtOH extracts in human colorectal cancer cell lines  

Park, Hyo-Hyun (Department of Korean Medicine Development, National Development Institute of Korean Medicine)
Park, Ji-Eun (Department of Korean Medicine Development, National Development Institute of Korean Medicine)
Son, Eun-Kyung (Department of Korean Medicine Development, National Development Institute of Korean Medicine)
Kim, Bo-Mi (Department of Korean Medicine Development, National Development Institute of Korean Medicine)
So, Jai-Hyun (Department of Korean Medicine Development, National Development Institute of Korean Medicine)
Publication Information
Journal of Applied Biological Chemistry / v.63, no.1, 2020 , pp. 103-110 More about this Journal
Abstract
Objective: The objective of our study was to investigate anti-cancer effects of Danggui Liuhuang Decoction extract bioconverted by protease liquid coenzyme of Aspergillus kawachii (DLD-BE), compared to a non-bioconverted DLD extract (DLD-E) and determine the underlying mechanisms. Methods: DLD-E and DLD-BE were evaluated for their ability to modulate these signaling pathways and suppress the proliferation of human colorectal cancer (CRC) cells, HCT-116, LoVo, and HT-29. The anti-cancer effects of DLD-E and DLD-BE were measured by using proliferation and migration assays, cell cycle analysis, Western blots, and real-time PCR. Results: In this study, treatment with DLD-E and DLD-BE at concentrations of 25-100 ㎍/mL inhibited proliferation and migration in human CRC cells. DLD-BE induced apoptotic cell death and decreased COX-2 expression in HT-29 cells. The mechanisms of action included modulation of the AKT and extracellular-signal-regulated kinase signaling cascades along with inhibition of COX-2 expression. The results demonstrate novel anti-cancer mechanisms of DLD-BE against the growth of human CRC cells. Thus, we propose that DLD-BE can be developed as a more potent supplement to inhibit colorectal tumor growth and intestinal inflammation than DLD-E.
Keywords
Bioconverted extract of Danggui Liuhuang Decoction; Colorectal cancer; Cyclooxygenase-2; Decoction extract; Extracellular-signal-regulated kinase; Liuhuang; Protein kinase B;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. J Am Med Am 284: 1247-1255   DOI
2 Lisse JR, Perlman M, Johansson G, Shoemaker JR, Schechtman J, Skalky CS, Dixon ME, Polis AB, Mollen AJ, Geba GP; ADVANTAGE Study Group (2003) Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial. Ann Intern Med 139: 539-546   DOI
3 Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ; VIGOR Study Group (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 343: 1520-1528   DOI
4 Hur J (2005; Originally published in 1610) Dongui Bogam. Yeogang Publishing Company, Seoul
5 Li DY. Lan Shi Mi Cang (2012; Originally published in 1276) China Tianjin Science and Technology Press, Tianjin
6 Kim DG, Kim KS (2007) Effects of dangkwiyughwangtang and okbyoungpoongsangamibang on the immune response induced by methotrexate in mice. J Korean Orient Pediatr 21: 189-209
7 Kim SB, Kang OH, Keum JH, Mun SH, Seo YS, Choi JG, Kim MR, Rho JR, Shin DW, Kil KJ, Kwon DY (2012) Anti-inflammatory effects of Danggui Liuhuang Decoction () in RAW 264.7 cells. Chin J Integr Med 1-7   DOI
8 Das D, Arber N, Jankowski JA (2007) Chemoprevention of colorectal cancer. Digestion 76: 51-67   DOI
9 Yang EJ, Kim SI, Park SY, Bang HY, Jeong JH, So JH, Rhee IK, Song KS (2012) Fermentation enhances the in vitro antioxidative effect of onion (Allium Cepa) via an increase in quercetin content. Food Chem Toxicol 50: 2042-2048   DOI
10 Vyas S, Zaganjor E, Haigis MC (2016) Mitochondria and Cancer. Cell 166: 555-566   DOI
11 Del Bufalo D, Biroccio A, Leonetti C, Zupi G (1997) Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line. FASEB J 11: 947-953   DOI
12 Pinkas J, Martin SS, Leder P (2004) Bcl-2-mediated cell survival promotes metastasis of EpH4 betaMEKDD mammary epithelial cells. Mol Cancer Res 2: 551-556
13 Wang D, Dubois RN (2008) Peroxisome proliferator-activated receptors and progression of colorectal cancer. Am J Respir Cell Mol Biol 39: 689-696   DOI
14 Halilovic E, She QB, Ye Q, Pagliarini R, Sellers WR, Solit DB, Rosen N (2010) PIK3CA mutation uncouples tumor growth and cyclin D1 regulation from MEK/ERK and mutant KRAS signaling. Cancer Res 70: 6804-6814   DOI
15 Wolter F, Akoglu B, Clausnitzer A, Stein J (2001) Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J Nutr 131: 2197-2203   DOI
16 Kelloff GJ, Fay JR, Steele VE, Lubet RA, Boone CW, Crowell JA, Sigman CC (1996) Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomarkers Prev 5: 657-666
17 Wang D, Dubois RN (2006) Prostaglandins and cancer. Gut 55: 115-122   DOI
18 Robert T, Elizabeth B, Fabio M, Madeine W (2015) Phytochemicals in cancer prevention and management? BJMP 8: a815
19 Lee SG, Kim JS, Lee HS, Lim YM, So JH, Hahn D, Ha YS, Nam JO (2017) Bioconverted Orostachys japonicas extracts suppress angiogenic activity of Ms-1 endothelial cells. Int J Mol Sci 18: 2615   DOI
20 Jung TD, Shin GH, Kim JM, Oh JW, Choi SI, Lee JH, Cho ML, Lee SJ, Heo IJ, Park SJ (2016) Changes in Lignan Content and Antioxidant Activity of Fermented Sesame (Sesame indicum L.) by Cultivars. J Korean Soc Food Sci Nutr 45: 143-148   DOI
21 Im AR, Song JH, Lee MY, Yeon SH, Um KA, Chae S (2014) Antiwrinkle effects of fermented and non-fermented Cyclopia Intermedia in hairless mice. BMC Complement. Altern Med 14: 424
22 Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adeno carcinomas. Gastroenterology 107: 1183-1188   DOI
23 Gao J1, Liu ZJ, Chen T, Zhao D (2014) Pharmaceutical properties of calycosin, the major bioactive isoflavonoid in the dry root extract of Radix astragali. Pharm Biol. 52(9): 1217-1222   DOI
24 El-Kott AF, Al-Kahtani MA, Shati AA (2019) Calycosin induces apoptosis in adenocarcinoma HT29 cells by inducing cytotoxic autophagy mediated by SIRT1/AMPK-induced inhibition of Akt/mTOR. Clin Exp Pharmacol Physiol. 46: 944-954   DOI
25 Kim SJ, Kim HJ, Kim HR, Lee SH, Cho SD, Choi CS, Nam JS, Jung JY (2012) Antitumor actions of baicalein and wogonin in HT-29 human colorectal cancer cells. Mol Med Rep. 6: 1443-1449   DOI
26 Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55: 3785-3789
27 Siegel R, Desantis C, Jemal A (2014) Colorectal cancer statistics, 2014. CA Cancer J Clin 64: 104-117   DOI
28 Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, Stenson WF (1998) Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115: 297-306   DOI
29 Hendel J, Nielsen OH (1997) Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease. Am J Gastroenterol 92: 1170-1173
30 Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN (1994) Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188   DOI
31 Niiro H, Otsuka T, Ogami E, Yamaoka K, Nagano S, Akahoshi M, Nakashima H, Arinobu Y, Izuhara K, Niho Y (1998) MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes. Biochem Biophys Res Commun 250: 200-205   DOI
32 Phillips WA, Clair FS, Munday AD, Thomas RJS, Mitchell CA (1998) Increased levels of phosphatidylinositol 3-kinase activity in colorectal tumors. Cancer 83: 41-47   DOI
33 Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64: 9-29   DOI
34 Sasaki T, Ine-Sasaki J, Hone J, Bachmeier K, Fata JE, Li M, Su A. (2000) Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kgamma. Nature 406: 897-902   DOI
35 Mazhar D, Ang R, Wazman J (2006) COX inhibitors and breast cancer. Br J Cancer 94: 346-350   DOI